Nicox SA (FR:ALCOX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nicox SA, an international ophthalmology company, is set to participate in several key industry conferences, including the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference and the 26th Annual Global Investment Conference. The company is known for innovative solutions in the ophthalmology space, with a focus on products like NCX 470 for glaucoma and ZERVIATE for allergic conjunctivitis. Nicox SA is listed on Euronext Growth Paris and is part of the CAC Healthcare index.
For further insights into FR:ALCOX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue